Benign neoplasm of appendix
ICD-10 D12.1 is a billable code used to indicate a diagnosis of benign neoplasm of appendix.
A benign neoplasm of the appendix is a non-cancerous tumor that arises from the tissues of the appendix. These neoplasms can include a variety of histological types, such as adenomas, carcinoid tumors, and other benign growths. While they are generally asymptomatic, they may occasionally present with abdominal pain, obstruction, or appendicitis-like symptoms. Diagnosis is typically made through imaging studies such as ultrasound or CT scans, and histological examination following surgical resection. Surveillance for these neoplasms is important, as some benign tumors, particularly carcinoid tumors, can have malignant potential, especially if they are larger than 2 cm or exhibit aggressive histological features. Regular follow-up and monitoring are recommended to ensure that any changes in size or symptoms are promptly addressed. The management of benign neoplasms of the appendix often involves surgical intervention, particularly if there is a risk of complications or if the neoplasm is symptomatic.
Detailed documentation of symptoms, imaging results, and histological findings.
Patients presenting with abdominal pain, incidental findings on imaging, or post-operative follow-up.
Ensure accurate coding of the neoplasm type and any associated procedures.
Operative reports detailing the surgical approach, findings, and pathology results.
Surgical resection of an appendiceal neoplasm, either incidentally or due to complications.
Document the rationale for surgery and any findings that may indicate malignancy.
Used when a benign neoplasm is surgically removed.
Operative report detailing the procedure and findings.
Ensure the neoplasm type is documented in the surgical report.
Common symptoms may include abdominal pain, nausea, and changes in bowel habits. However, many benign neoplasms are asymptomatic and found incidentally during imaging or surgery.
Surveillance frequency depends on the type and size of the neoplasm. Generally, patients should have follow-up imaging every 6 to 12 months, especially for carcinoid tumors larger than 2 cm.
